Cystatin C and the risk of death and cardiovascular events among elderly persons
about
A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart StudyAdiponectin regulates albuminuria and podocyte function in miceCystatin C and aging successCystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyAssociation of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul StudyEstimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKDRenalase and Biomarkers of Contrast-Induced Acute Kidney InjuryChronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?Advances in the use of multimarker panels for renal risk stratificationEstimating glomerular filtration rate in older peopleBiomarkers in nephrology: Core Curriculum 2013Established and emerging markers of kidney functionCystatin C: a new renal marker and its potential use in small animal medicineEvaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistancesBiomarkers in chronic kidney disease, from kidney function to kidney damageCystatin C and preeclampsia: a case control studyAssociation of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD PatientsGDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in menHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverCystatin C and Cardiovascular Disease: A Mendelian Randomization Study.Urinary biomarkers as a diagnostic tool for acute kidney injury.Occult chronic kidney disease among persons with hypertension in the United States: data from the National Health and Nutrition Surveys 1988-1994 and 1999-2002.Assessment of renal function; clearance, the renal microcirculation, renal blood flow, and metabolic balance.Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul StudyCystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data.Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study.Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline dataCKD associates with cognitive decline.Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).Hip fractures and heart failure: findings from the Cardiovascular Health Study.Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).Impaired kidney function and atrial fibrillation in elderly subjects.Association of cystatin C with ischemia in patients with coronary heart disease.Screening for chronic kidney disease in HIV-infected patients.Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.Biomarkers of nephrotoxic acute kidney injuryProteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease.Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.
P2860
Q21261435-57260D5D-58BE-4E5F-9FF9-9ECB0E19F8C6Q24324384-C824AC0D-4E16-42B6-A49C-DAF1E2273D97Q24615859-31A42742-69BB-4483-8ADF-291BE5276B74Q24635177-5C45876C-E8BD-4417-AE5F-EE243C15FE9DQ24646339-ACE3384A-CE39-485F-9DE2-200E6F9BC16AQ24652643-F42D3798-2A15-42A2-AB48-8DB380328D89Q26748488-09F9F97D-1447-4741-8162-7724E000A1DCQ26748992-9A8ACB0D-B2A0-4AC9-AED5-D4A926809EE9Q26853272-68C0F68D-4F4C-40CC-9418-98DAD8179057Q26860026-AA4EF49A-EE9E-4514-B854-60F414877CC6Q26861451-765437EC-ADE1-41A7-8E77-B76DE9F082BEQ26864498-97EF3F29-450B-4751-A516-BB236779F577Q27010861-2D176D63-B1E8-4869-AF58-AE3165269C06Q28084462-678C6D39-506B-4EE2-AF2B-5C1C0E869BC6Q28087304-007654C1-9B02-44B9-9E26-D5FD15B561E0Q28264774-C0962002-D641-4C7F-96ED-900EEF35EE49Q28277765-EE321FC1-AB89-49FE-AE55-CBB29A8A21E1Q28535575-9211201E-B2B9-4E19-BA0D-07A664474A8EQ29616840-CAF962D7-5069-4194-8297-B6FA45C1D023Q30276065-5D57ABF9-65C3-433D-8027-1B4EA2C58A5AQ30450879-E8D3713D-281E-422C-8681-A5F0F68972F5Q30620940-554069EA-3A68-4B55-9EAE-2EB0F4C96DF5Q30636047-1840EA91-AFBD-4F3D-A3EC-BE8FB5BBE239Q31058094-F4851F81-0345-49D3-9851-23F6E3669317Q31067194-C38CCC77-1420-4519-9147-FA2A8AD723F1Q31071745-D1CBFA65-D918-4E25-A3B8-5FB9EC3097BCQ33276760-A1DB55DE-0B28-44A2-8AB2-1E4E2ED3027FQ33402590-1104DC18-0068-452D-92A1-32DC08518E21Q33550730-D30FDAE6-89DE-4AAE-9299-53453271D68CQ33561710-D0494264-3CF6-4C7B-A450-F45C043D0C24Q33562005-5371A242-65AE-4511-B4A8-62B5926EA9DCQ33568103-7D98C1C8-BD56-4AB0-86AA-8F1EF8CC75AAQ33591588-A7C65609-D0C2-4153-8BB4-D8876A58DB7CQ33635948-5845F782-713B-452D-8FB1-93E2A15F808BQ33637144-EDC9BD0A-EF79-4F05-8F3B-42E9B32D1607Q33639802-FDB029BF-A293-4542-B8B2-C9737049FA76Q33646576-89E8A962-1B11-4417-95C6-1B5D05708FD9Q33687717-91D2BCF5-2D1B-4624-A54A-6A6EDB5384A8Q33710875-2BA1C8F7-B5A8-47DF-8B19-DF23AD8CB5EEQ33721299-B1548EBC-4EFC-4B5F-AF10-7F8341AFBB9E
P2860
Cystatin C and the risk of death and cardiovascular events among elderly persons
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cystatin C and the risk of death and cardiovascular events among elderly persons
@ast
Cystatin C and the risk of death and cardiovascular events among elderly persons
@en
Cystatin C and the risk of death and cardiovascular events among elderly persons
@nl
type
label
Cystatin C and the risk of death and cardiovascular events among elderly persons
@ast
Cystatin C and the risk of death and cardiovascular events among elderly persons
@en
Cystatin C and the risk of death and cardiovascular events among elderly persons
@nl
prefLabel
Cystatin C and the risk of death and cardiovascular events among elderly persons
@ast
Cystatin C and the risk of death and cardiovascular events among elderly persons
@en
Cystatin C and the risk of death and cardiovascular events among elderly persons
@nl
P2093
P50
P3181
P356
P1476
Cystatin C and the risk of death and cardiovascular events among elderly persons
@en
P2093
Catherine Stehman-Breen
Linda F Fried
Mark J Sarnak
P304
P3181
P356
10.1056/NEJMOA043161
P407
P577
2005-05-19T00:00:00Z